Recent Company News

• 03:55 AM ET Dec 01, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (72 total)

• 04:26 AM ET Nov 26, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (57 total)

• 04:46 AM ET Nov 25, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (61 total)

• 02:54 AM ET Nov 25, 2025
  

  StreetAccount Summary - European pre-market trading update

• 02:47 AM ET Nov 25, 2025
  

  Galderma Group upgraded to buy from neutral at UBS (CHF 149.70, 0.00)

• 01:01 AM ET Nov 17, 2025
  

  Galderma announced that it presented new data from its Injectable Aesthetics portfolio and pipeline at the American Society for Dermatologic Surgery (ASDS) 2025 Annual Meeting, held in Chicago from November 13-16 (CHF 149.50, 0.00)

• 03:54 AM ET Nov 13, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (101 total)

• 01:09 AM ET Nov 05, 2025
  

  Galderma Group announces US FDA approves Restylane Lyft with Lidocainefor augmentation of the chin region to improve the chin profile in patients over the age of 21 with mild-to-moderate chin retrusion (CHF 153.30, 0.00)

• 04:06 AM ET Nov 03, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (98 total)